The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.

Specific PHGKB|Cancer|PHGKB

Endometrial Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Dec 07, 2017

---

• The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.  
  Chang Cheng Chang et al. Journal of gynecologic oncology 2018 Jan 29(1) e17
• Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.  
  Saule Claire et al. Journal of the National Cancer Institute 2018 Feb (2)
• An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.  
  Cosgrove Casey M et al. Gynecologic oncology 2017 Nov
• Genetic anticipation in Swedish Lynch syndrome families.  
  von Salomé Jenny et al. PLoS genetics 2017 Oct 13(10) e1007012
• Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.  
  Lynch Henry T et al. Familial cancer 2017 Oct
• Universal Screening for Lynch Syndrome in Endometrial Cancers: Frequency of Germline Mutations and Identification of Patients with Lynch-Like Syndrome.  
  Dillon Jessica L et al. Human pathology 2017 Oct
• Value-based healthcare in Lynch syndrome.  
  Hennink Simone D et al. Familial cancer 2013 Jun 12(2) 347-54
• Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.  
  Snowsill Tristan et al. Health technology assessment (Winchester, England) 2017 Sep 21(51) 1-238
• Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer.  
  Takahashi Kazue et al. Gynecologic oncology 2017 Aug
• Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.  
  Johnatty Sharon E et al. Gynecologic oncology 2017 Aug